Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India

BACKGROUND & AIMS: Availability of directly-acting antivirals (DAAs) has changed the treatment landscape of hepatitis C virus (HCV) infection. The high price of DAAs has restricted their use in several countries. However, in some countries such as India, generic DAAs are available at much cheape...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Aggarwal, Rakesh, Chen, Qiushi, Goel, Amit, Seguy, Nicole, Pendse, Razia, Ayer, Turgay, Chhatwal, Jagpreet
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5435174/
https://ncbi.nlm.nih.gov/pubmed/28520728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0176503
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak